ImmunoGenesis
Doylestown, PA
Works in Dermatology · GI & liver · Metabolic & endocrine · Oncology · Renal & urogenital · Respiratory
ImmunoGenesis is a clinical trial sponsor based in Doylestown, PA. It has 2 active clinical trials with 176 planned participants, across 6 therapeutic areas. Since 2021 it has completed 3 trials and stopped 3 early.
Trial track record · since 2021
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about ImmunoGenesis
ImmunoGenesis is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 176 planned participants, in Dermatology, GI & liver, Metabolic & endocrine, Oncology and other areas. Since 2021 it has completed 3 trials and stopped 3 early.
ImmunoGenesis is based in Doylestown, PA. The address is the one on its FDA records or ClinicalTrials.gov registrations, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with ImmunoGenesis; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-04.
Approve Suite is not affiliated with ImmunoGenesis.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.